N/A
N=250
Promoting Recovery Optimization With WALKing Exercise After Stroke
Stroke
Bottom Line
View on ClinicalTrials.gov: NCT02835313 ↗Enrolled (actual)
250
Serious AEs
10.4%
Results posted
Oct 2024
Primary outcome: Primary: Steps Per Day — 1307; 406; 1542 steps per day
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- FAST alone (Behavioral); FAST+SAM (Behavioral); SAM alone (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- All
- Sponsor
- University of Delaware
- Primary completion
- Jan 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Steps Per Day |
-568; -610; -1072 | — |
| PRIMARY Steps Per Day |
-568; -610; -1072 | — |
| PRIMARY Steps Per Day |
-568; -610; -1072 | — |
| SECONDARY Six-minute Walk Test Distance |
-18; -21; -16 | — |
| SECONDARY Six-minute Walk Test Distance |
-18; -21; -16 | — |
| SECONDARY Six-minute Walk Test Distance |
-18; -21; -16 | — |
| SECONDARY Self-selected Gait Speed |
-0.02; -0.05; -0.04 | — |
| SECONDARY Self-selected Gait Speed |
-0.02; -0.05; -0.04 | — |
| SECONDARY Self-selected Gait Speed |
-0.02; -0.05; -0.04 | — |
| SECONDARY Oxygen Consumption |
-0.08; -1.32; -0.15 | — |
| SECONDARY Oxygen Consumption |
-0.08; -1.32; -0.15 | — |
| SECONDARY Oxygen Consumption |
-0.08; -1.32; -0.15 | — |
Summary
Stroke survivors, as a group, are extremely inactive and this has serious consequences for them, including an increased risk of a second stroke and developing other diseases. This study investigates a novel intervention designed to improve everyday activity after stroke by combining walking training to improve walking capacity with a program to encourage more daily walking.
Eligibility Criteria
Inclusion Criteria
- Age 21-85
- Chronic stroke (>6 months post stroke)
- Able to walk at self-selected speed without assistance from another person (assistive devices are allowed)
- Self-selected walking speed >0.3 m/s and 1 on question 1b and >0 on question 1c on the NIH Stroke Scale.
Data sourced from ClinicalTrials.gov (NCT02835313). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.